Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sosondowah ankyrin repeat domain family member B (SOWAHB; also referred to as ANKRD56 or ankyrin repeat domain-containing protein SOWAHB) is a human gene encoding a protein containing ankyrin repeats, a highly conserved protein motif involved in mediating protein-protein interactions[5]. However, despite the presence of ankyrin repeats, there is currently very limited information available about the specific biological function, molecular interactions, or disease associations of SOWAHB in the scientific literature and protein/gene databases. Important notes on correctness: - The designation "SOWAHB" and its full forms refer to a real human gene/protein but currently have no well-documented biological functions, disease roles, or relevance as a therapeutic target in respected scientific or medical resources. - No evidence in the literature suggests that SOWAHB is a receptor, enzyme, transporter, or any established therapeutic target; it is classified simply as an "ankyrin repeat-containing protein" within gene/protein family databases[5]. - Information for functions, disease roles, biomarkers, safety concerns, and interacting drugs is unknown or missing. This should be considered not a validated therapeutic target and information provided in background sources is insufficient to classify this protein as clinically or pharmacologically relevant under standard criteria. If you need structured data for a database or application, all functional/disease/drug/biomarker fields should be considered null or unknown, and *is_incorrect* should be marked true to indicate likely lack of utility as a drug target or biomarker.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sosondowah ankyrin repeat domain family member B (SOWAHB).